Clinical Trials Are Heavily Influenced by Drug Companies

Simple item page
dc.contributor.authorLexchin, Joel
dc.date.accessioned2015-05-21T17:50:40Z
dc.date.available2015-05-21T17:50:40Z
dc.date.issued2011
dc.descriptionen_US
dc.description.abstractDespite its stated interest in openness and transparency, Health Canada continues to deny the public access to information about clinical trials. It is also moving at a snail’s pace in developing a policy on clinical trials registration. Health Canada seems to be putting the drug industry’s needs ahead of the public good.en_US
dc.description.sponsorshipYork's Knowledge Mobilization Unit provides services and funding for faculty, graduate students, and community organizations seeking to maximize the impact of academic research and expertise on public policy, social programming, and professional practice. It is supported by SSHRC and CIHR grants, and by the Office of the Vice-President Research & Innovation. kmbunit@yorku.ca www.researchimpact.caen_US
dc.identifier00158
dc.identifier.citationLexchin, J. (2008). Clinical trials in Canada: Whose interests are paramount? International Journal of Health Services, 38(3), 525-542.en_US
dc.identifier.urihttp://hdl.handle.net/10315/29217
dc.relationYork Universityen_US
dc.relation.urien_US
dc.rightsAttribution-Noncommercial-No Derivative Works 2.5 Canadaen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ca/en_US
dc.subjectHealthen_US
dc.subjectBusinessen_US
dc.titleClinical Trials Are Heavily Influenced by Drug Companiesen_US
dc.typeResearch Summaryen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
00158.pdf
Size:
264.18 KB
Format:
Adobe Portable Document Format
Download

Collections

Research Summaries

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.